This alliance brings together Kent’s tissue evaluation tools, SnapshotNIR and SnapshotGLO, with Marathon Medical’s over two decades of expertise in supporting the VA.
This partnership continues to advance our mission of improving outcomes for patients by making Kent Imaging’s technology more accessible to Veterans and the broader government healthcare community.”— Pierre Lemire, CEO
CALGARY, AB – ALBERTA, CANADA, August 26, 2026 /EINPresswire.com/ — Kent Imaging Inc., a frontrunner in near-infrared tissue oxygenation and bacterial autofluorescence imaging, has unveiled a new collaboration with Marathon Medical Corporation, a Service-Disabled Veteran-Owned Small Business (SDVOSB) that focuses on federal healthcare distribution. Together, the two entities will broaden the availability of Kent Imaging’s sophisticated wound imaging systems across U.S. Department of Veterans Affairs (VA) medical facilities, enabling clinicians to detect patients at risk for wound complications at an earlier stage and foster improved outcomes for America’s Veterans.
This alliance merges Kent Imaging’s point-of-care tissue assessment devices, SnapshotNIR and SnapshotGLO, along with any subsequent product advancements, with Marathon Medical’s more than 20 years of service to the VA, Department of Defense, and other federal health agencies. Marathon Medical, established by Vietnam Veteran John St. Leger, has grown its operations around supporting the federal healthcare system that serves those who have served the nation.
Chronic wounds and lower extremity complications remain a major health challenge among the Veteran population, especially for those living with diabetes and peripheral arterial disease (PAD). By delivering objective data on tissue oxygenation and bacterial load at the bedside, Kent Imaging’s solutions aid earlier clinical decision-making to enhance healing outcomes and lower preventable amputations.
“This partnership continues to advance our mission of improving outcomes for patients by making Kent Imaging’s technology more accessible to Veterans and the broader government healthcare community,” said Pierre Lemire, CEO of Kent Imaging. “We are proud to work with Marathon Medical to bring innovative imaging solutions to the clinicians who care for patients in need.”
“Echoing that commitment, this partnership gives us an opportunity to put that mission into action by expanding access to advanced wound imaging where it can make a meaningful difference in patient care,” adds Chris Tiemann, Vice President of Sales, Kent Imaging.
As a Service-Disabled Veteran-Owned Small Business, Marathon Medical is committed to providing top-tier medical products and professional, tailored service throughout the federal healthcare system. The company collaborates closely with VA hospitals, military treatment facilities, and other government entities to ensure that providers have timely access to innovative medical technologies.
"At Marathon Medical, our mission has always been to serve those who served. We are pleased to have Kent Imaging’s Snapshot suite as part of that mission," said Jon Landis, Chief Commercialization Officer, Marathon Medical.
This alliance highlights both organizations’ dedication to advancing Veteran Healthcare through innovation while strengthening ties between medical technology firms and veteran-owned businesses focused on serving the federal healthcare community.
About Kent Imaging
Headquartered in Calgary, Alberta, Canada, Kent Imaging is a pioneering force in advanced imaging technology. The company designs, manufactures, and markets medical devices that facilitate real-time decision-making in wound care, vascular, and surgical fields. Through patented technologies, Kent continues to deliver groundbreaking solutions that support healthcare systems globally.
The Snapshot product suite now comprises two powerful imaging devices: SnapshotNIR, a near-infrared tissue oxygenation imaging device initially cleared by the FDA and Health Canada in 2017 and CE-marked in 2025; and SnapshotGLO, a bacterial autofluorescence imaging device that obtained FDA 510(k) clearance in 2025. SnapshotNIR is backed by clinical evidence demonstrating its role in improving clinical decision-making, while SnapshotGLO offers real-time insight into wound bioburden presence and distribution. Together, the Snapshot product family enhances clinicians’ ability to detect, direct, and protect—promoting treatment consistency, supporting improved workflow, and contributing to better patient care worldwide.
SnapshotGLO® is a registered trademark of Kent Imaging Inc.
SnapshotNIR® is a registered trademark of Kent Imaging Inc.
About Marathon Medical
Established in 2002, Marathon Medical Corporation is a Service-Disabled Veteran-Owned Small Business (SDVOSB) based in Aurora, Colorado. The company specializes in delivering medical products to the U.S. Department of Veterans Affairs, Department of Defense, and other federal healthcare agencies, with a mission to provide excellence in the healthcare supply chain through professional, personal service.
Leah Pavlick
Kent Imaging Inc.
leah@kentimaging.com
Visit us on social media:
LinkedIn
